ADNKronos Immediapress

"Remember. August 23" - international public awareness and educational campaign about the victims of totalitarian regimes

(Adnkronos) - WARSAW, Poland, Aug. 22, 2023 /PRNewswire/ -- 23 August marks the European Day of Remembrance for Victims of all Totalitarian and Author...

ERLING HAALAND NOMINATO BRAND AMBASSADOR DI MIDEA

(Adnkronos) - MANCHESTER, Inghilterra, 22 agosto 2023 /PRNewswire/ -- Midea, leader mondiale nella produzione di grandi e piccoli elettrodomestici, ha...

Westport Announces Resignation of David Johnson, Chief Executive Officer, and Names Interim CEO

(Adnkronos) - VANCOUVER, BC, Aug. 22, 2023 /PRNewswire/ -- Westport Fuel Systems Inc. (TSX: WPRT) (Nasdaq: WPRT), a leading supplier of advanced alter...

Novavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6

(Adnkronos) - GAITHERSBURG, Md., Aug. 22, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with it...

Veeva Vault LIMS to Support Civica Rx Quality Control

(Adnkronos) - Nonprofit generic drug manufacturer building foundation for end-to-end quality management BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ ...

VOLO Events Agency, an Experiential Marketing Firm, Ranked #1 by INC. Magazine

(Adnkronos) - ATLANTA, Aug. 22, 2023 /PRNewswire/ -- VOLO Events Agency, a leading producer of live events and experiential marketing, has been named ...

COP28 announces innovative thematic program to progress action on its goals across Just Energy Transition, Finance, Health, Lives & Livelihoods and Inclusivity

(Adnkronos) - ABU DHABI, UAE, Aug. 22, 2023 /PRNewswire/ -- The COP28 UAE Presidency has announced an ambitious and inclusive two-week thematic progra...

Former Head of Third-Party Information Security Risk Oversight at Standard Chartered Bank Joins BlueVoyant

(Adnkronos) - Jon Leather appointed as head of European Supply Chain Defence advisory LONDON, Aug. 22, 2023 /PRNewswire/ -- BlueVoyant, a cyber secur...

Paradigm Therapeutics acquisisce la "terapia rivoluzionaria" in fase avanzata per il trattamento di tutti i sottotipi di Epidermolysis Bullosa (EB)

(Adnkronos) - "Terapia topica per il trattamento di ferite e lesioni sull'intera superficie cutanea" MT PLEASANT, S.C., 22 agosto 2023 /PRNewswire/...

Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)

(Adnkronos) - 'Topical Therapy for Treating the Wounds and Lesions on the Entire Skin Surface' MT PLEASANT, S.C., Aug. 22, 2023 /PRNewswire/ -- Parad...